Skip to main content

UroGen Pharma Ltd 10-Q for FY2025 Q3

UroGen Pharma Ltd. (URGN)

10-Q 2025-11-06 For: 2025-09-30
View Original
Added on April 07, 2026

About this 10-Q

UroGen Pharma Ltd filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$27.48M
up 9.0% from $25.2M a year earlier
Net loss
$33.35M
compared with a net loss of $23.67M a year earlier